H-L-Tyr(tBu)-OMe*HCl is a protected tyrosine derivative in which the phenolic side chain is tert-butyl-protected (Tyr(tBu)) and the carboxyl group is converted to a methyl ester (OMe), with the free amino group presented as a hydrochloride salt (HCl). The molecule contains an N-terminal amino functionality (H-L- indicates the specified stereochemical form), a tert-butyl-protected phenolic oxygen that reduces phenol reactivity, and an esterified carboxyl group that changes acidity and solubility relative to the free amino acid. This protected amino acid ester hydrochloride is used as a building block for peptide and peptide-like synthesis where side-chain protection and carboxyl masking support controlled coupling and stepwise assembly, and it can also be employed in analytical or labeling workflows that require a tyrosine scaffold with suppressed phenolic reactivity.
CAT No: CP25869
CAS No:51482-39-4
Synonyms/Alias:51482-39-4;H-Tyr(tbu)-omehcl;(S)-Methyl2-amino-3-(4-(tert-butoxy)phenyl)propanoatehydrochloride;O-tert-Butyl-L-tyrosinemethylesterhydrochloride;ST51037718;H-Tyr(tBu)-Ome.HCl;H-TYR-OMEHCL;MethylO-tert-butyl-L-tyrosinatehydrochloride;96627_ALDRICH;AC1O55G5;SCHEMBL1310837;96627_FLUKA;CTK6I6443;MolPort-003-939-955;EINECS257-234-3;MethylO-tert-butyl-L-tyrosinateHCl;AKOS016003503;AK-81060;KB-211809;TC-165590;AM20040605;ST24036323;V0214;K-9459;O-T-BUTYL-L-TYROSINEMETHYLESTERHYDROCHLORIDE
Chemical Name:O-t-Butyl-L-tyrosine methyl ester hydrochloride
H-L-Tyr(tBu)-OMe*HCl is an L-tyrosine-derived amino acid methyl ester hydrochloride bearing a tert-butyl-protected phenolic side chain, where the aromatic ring retains the phenolic oxygen as a sterically shielded tBu ether. The molecule combines an esterified carboxyl group (methyl ester) with an N-terminal amino functionality that is present as a salt form, and it presents a defined stereocenter consistent with L-configuration for peptide-compatible coupling. The tert-butyl ether on the tyrosine side chain modulates phenolic reactivity during amide bond formation and can be removed under acidolytic conditions to regenerate the free phenol for downstream conjugation or derivatization. The hydrochloride salt form improves handling of the amino ester while maintaining a protected side chain pattern suitable for protected amino acid synthesis and peptide building block preparation.
1. Protected Amino Acid Synthesis
H-L-Tyr(tBu)-OMe*HCl is applied in protected amino acid chemistry and chiral intermediate preparation because the methyl ester and phenolic tert-butyl protection provide orthogonal handles for controlled functional group transformations. The protected tyrosine side chain suppresses phenol participation in coupling steps, while the N-terminal amino salt and ester carbonyl enable activation strategies for peptide coupling or conversion to other activated carboxyl derivatives. The L-tyrosine stereochemistry is preserved through ester-based synthetic sequences, supporting stereochemically consistent downstream peptide construction. The compound can be used as a defined intermediate for manufacturing routes that require tyrosine-containing protected building blocks with minimized side reactions.
2. Peptide Synthesis
H-L-Tyr(tBu)-OMe*HCl is suitable for peptide synthesis workflows where tyrosine residues are incorporated with a protected phenolic group to prevent undesired O-alkylation, acylation, or oxidation during chain assembly. The amino ester hydrochloride form supports peptide coupling chemistry after appropriate conversion to an activated carboxyl equivalent, while the tert-butyl ether protects the phenolic oxygen throughout N-terminal activation and amide bond formation. The aromatic side chain can later be deprotected to yield a free phenol for post-coupling modifications such as esterification, ether formation, or conjugation to labels and linkers. The defined L-configuration and orthogonal protection pattern make the compound compatible with iterative peptide building block preparation and peptidomimetic analog assembly.
3. Bioconjugation Chemistry
H-L-Tyr(tBu)-OMe*HCl supports bioconjugation and chemical biology workflows through its tyrosine-derived phenolic functionality that can be revealed by tert-butyl deprotection after peptide or scaffold assembly. The protected phenol enables stable handling during synthesis of tyrosine-containing peptides, antibody fragments, or protein-binding ligands where uncontrolled phenolic reactivity would complicate purification and coupling. The regenerated phenol can participate in electrophilic aromatic substitution, oxidative coupling strategies, or formation of phenoxy linkages depending on the chosen conjugation chemistry, enabling attachment of fluorophores, affinity tags, or immobilization handles. The amino acid ester and N-terminal salt pattern provide a structured route to tyrosine-containing conjugation-ready intermediates for downstream biomolecule modification.
4. Peptidomimetics And SAR Studies
H-L-Tyr(tBu)-OMe*HCl is utilized in peptidomimetic construction and structure-activity relationship studies where tyrosine side-chain chemistry and stereodefined amino acid incorporation influence molecular recognition. The protected phenolic ether allows systematic generation of analog libraries by enabling controlled deprotection followed by side-chain functional group diversification without perturbing the peptide backbone during synthesis. The methyl ester functionality can serve as a synthetic handle for conversion to amides, acids, or other carboxyl derivatives that support scaffold tuning in SAR workflows. The stereochemically defined L-tyrosine framework and orthogonal protection strategy facilitate reproducible synthesis of analogs used to probe binding-site interactions and side-chain contributions.
5. Process Chemistry Intermediate
H-L-Tyr(tBu)-OMe*HCl functions as a process chemistry intermediate for industrial fine chemical synthesis where stable protection of the tyrosine phenol and predictable salt handling reduce variability in multi-step manufacturing. The tert-butyl ether protection pattern can be carried through coupling and intermediate formation steps, supporting batch-to-batch consistency by limiting phenolic side reactions during scale-up. The amino acid methyl ester hydrochloride form provides a practical starting form for conversion to activated carboxyl species or for downstream ester-to-amide transformations in controlled process sequences. The compound's defined stereochemistry and orthogonal protecting-group logic make it compatible with manufacturing routes aimed at producing protected tyrosine building blocks for peptide-grade supply chains.
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.